Septin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV by Akil, Abdellah et al.
HAL Id: hal-01355643
https://hal.archives-ouvertes.fr/hal-01355643
Submitted on 18 Nov 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
Septin 9 induces lipid droplets growth by a
phosphatidylinositol-5-phosphate and
microtubule-dependent mechanism hijacked by HCV
Abdellah Akil, Juan Peng, Mohyeddine Omrane, Claire Gondeau, Christophe
Desterke, Mickaël Marin, Hélène Tronchère, Cyntia Taveneau, Sokhavuth Sar,
Philippe Briolotti, et al.
To cite this version:
Abdellah Akil, Juan Peng, Mohyeddine Omrane, Claire Gondeau, Christophe Desterke, et al..
Septin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-
dependent mechanism hijacked by HCV. Nature Communications, Nature Publishing Group, 2016, 7,
￿10.1038/ncomms12203￿. ￿hal-01355643￿
ARTICLE
Received 31 Aug 2015 | Accepted 7 Jun 2016 | Published 15 Jul 2016
Septin 9 induces lipid droplets growth by
a phosphatidylinositol-5-phosphate and
microtubule-dependent mechanism hijacked
by HCV
Abdellah Akil1,2,3,4,*, Juan Peng1,2,5,*, Mohyeddine Omrane1,2,5,*, Claire Gondeau6,7, Christophe Desterke8,
Mickae¨l Marin1,2, He´le`ne Tronche`re9, Cyntia Taveneau10, Sokhavuth Sar1,2, Philippe Briolotti6,7,
Soumaya Benjelloun3, Abdelaziz Benjouad4,11, Patrick Maurel6,7, Vale´rie Thiers12, Ste´phane Bressanelli10,
Didier Samuel1,2,5,13, Christian Bre´chot1,2,12 & Ama Gassama-Diagne1,2,5
The accumulation of lipid droplets (LD) is frequently observed in hepatitis C virus (HCV)
infection and represents an important risk factor for the development of liver steatosis and
cirrhosis. The mechanisms of LD biogenesis and growth remain open questions. Here,
transcriptome analysis reveals a significant upregulation of septin 9 in HCV-induced cirrhosis
compared with the normal liver. HCV infection increases septin 9 expression and induces its
assembly into filaments. Septin 9 regulates LD growth and perinuclear accumulation in a
manner dependent on dynamic microtubules. The effects of septin 9 on LDs are also
dependent on binding to PtdIns5P, which, in turn, controls the formation of septin 9 filaments
and its interaction with microtubules. This previously undescribed cooperation between
PtdIns5P and septin 9 regulates oleate-induced accumulation of LDs. Overall, our data offer a
novel route for LD growth through the involvement of a septin 9/PtdIns5P signalling pathway.
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L
ipid droplets (LDs) are highly dynamic organelles generated
from the endoplasmic reticulum (ER)1, which can remain
attached to the ER or generate contacts with other
organelles, including the mitochondria, lysosomes, peroxisomes
and Golgi2. LDs consist of a hydrophobic core of neutral lipids,
which are primarily composed of triacylglycerols (TAGs) and
cholesterol esters, surrounded by a monolayer of phospholipids
and a large group of proteins that facilitate cellular signalling
interactions, control the access of metabolic enzymes, and
influence LD movement within the cell1,3. These proteins
include predominantly the perilipin family (Plins) and proteins
of the rab family of GTPases1,4. There are five known perilipins
(PLINs 1–5) expressed in hepatocytes, which play distinct roles.
PLIN2 also called ADRP (adipose differentiation-related protein)
is a prominent LD protein, expression level of which is tied to LD
accumulation. PLIN3 initially described as a tail-interacting
protein of 47 kDa (TIP47) is also ubiquitously expressed5. LD
growth and degradation are highly regulated processes and
excessive accumulation of LDs in the liver causes steatosis, which
may contributes to cirrhosis, the final stage for several chronic
liver diseases and often evolves to hepatocellular carcinoma.
Chronic HCV infection is a major public health problem and a
main risk factor for cirrhosis, and hepatocellular carcinoma, thus
remaining the major cause of liver resection and transplantation6.
There is no vaccine to protect against HCV, although major
advances have been recently achieved regarding HCV infection
treatment, and the combination of drugs, including protease
inhibitors, represents a real breakthrough that cure almost 90% of
infected patients. However, these treatments have remained very
costly. Additionally, understanding the key mechanisms driving
HCV replication and persistence will have a profound impact,
beyond HCV, for the appraisal of the pathogenesis of this family
of viruses. Each step of the replication cycle of HCV is tightly
dependent on the host lipid metabolism, and liver steatosis
associated with the accumulation of LDs is a hallmark of chronic
HCV infection7,8. HCV and LD interactions are crucial for
persistent viral propagation and virion production9.
HCV is an enveloped positive single-stranded RNA virus from
the Flaviviridae family. HCV genomic RNA encodes for a
polyprotein precursor ofB3,100 amino acids post-translationally
cleaved by cellular and viral proteases into the structural (core, E1
and E2), non-structural (NS) proteins (NS2, NS3, NS4A, NS4B,
NS5A and NS5B) and p7 protein8. The core protein plays a major
role in the virion assembly through interaction with LDs10.
The proteins covering the LD surface and their link with HCV
life cycle have been characterized, whereas the potential role
of phospholipids in these events remains unclear. The
composition of the phospholipid monolayer of LDs depends on
the cell type, but is mostly composed of phosphatidylcholine,
phosphatidylethanolamine, and, to a lesser extent,
phosphatidylinositol (PtdIns) and lysophospholipids1,11,12. The
phosphorylated derivatives of PtdIns (PIs) are important
signalling molecules that are essential for a variety of cellular
functions, including membrane remodelling and trafficking13.
Although recent studies revealed the role of PtdIns 4-kinases
(PI4K-IIIa and PI4K-IIIb) and their lipid products, PtdIns4P,
as critical regulators of the HCV life cycle8. The role of class II
phosphoinositide 3-kinase (PI3K) was also demonstrated14.
Furthermore we demonstrated that PIs control epithelial
morphogenesis and polarity15,16 and represent HCV cellular
targets17.
Septins form a family of GTP-binding proteins composed of 13
members in mammals and conserved from yeast to humans18.
The complexity of this gene family is increased by the existence of
alternative splicing, which markedly increases the number of
potential isoforms. Septins assemble into complexes variable in
size and composition between organisms19,20. In drosophila and
mammalian septins, complexes contain in general three to four
different septins present in two copies. The core hetero-
oligomeric units of six to eight subunits serve to build higher
order structures, including filaments and rings structures, which
are important for septin in vivo biological function20. Septins are
implicated in multiple cellular functions, including cytokinesis,
ciliogenesis, cell migration, vesicle trafficking, and cell
polarity21–23. Septins associate with the cytoskeleton and are
known as a fourth type of cytoskeletal structure23. Septins also
bind to membranes, specifically to PIs, providing membrane
stability and serving as diffusion barriers for membrane
proteins20,21,23. Nevertheless, these septin/PI interactions have
been scarcely investigated24–26 and their link with HCV life cycle
and their potential role in LD biogenesis and growth remain
unclear. Septins are also involved in infection by pathogens,
including bacteria, fungi23,27,28 and HCV virus29. Alteration in
expression profile of septins are reported in different cancers and
we determined that septin 9 is specifically upregulated in liver
cancer30.
Despite being involved in carcinogenesis, septin 9 expression
and function have not been investigated in precancerous diseases
such as cirrhosis. In this study, we investigate the expression of
septin 9 and the differential expression of the other septins in
HCV-induced cirrhosis. We also demonstrate that septin 9
regulates LD growth through binding to PtdIns5P in HCV-
infected cells. Of interest, we show that this new mechanism is
involved in lipid homoeostasis independently of HCV infection.
Results
Transcriptomic analysis of septins in human cirrhosis. To
determine the expression profile of septin 9 in cirrhosis, we used
the GSE14323 data set31, including transcriptomes of normal liver
(n¼ 19) and HCV-induced cirrhosis samples (n¼ 49). Data
revealed a significant upregulation (two-sided Student’s t-test,
P¼ 0.012) of septin 9 transcriptional expression in cirrhosis
samples compared to that in normal liver samples (Fig. 1a).
Septin 9 occupies a terminal position in an octameric septin
complex involved in the formation of higher order structures
such as filaments and rings (Fig. 1b)32. According to the
importance of hetero-oligomerisation in the assemblies and
functions of septins23, we assessed the differential expression of
septins in HCV-induced cirrhosis using the GSE14323 data set by
unsupervised principal component analysis (Fig. 1c–f). Sample
projection on the first factorial map showed a significant
separation between the normal liver and HCV-induced
cirrhosis samples according to the first axis (P¼ 2.67E 15)
(Fig. 1c). Learning machine algorithm of Random Forest
confirmed a good separation of the normal liver and cirrhosis
samples. The classification error by class was low and especially
null for the cirrhosis class after building 500 classification trees
and multidimensional Scaling plot (MDSplot), confirming the
good separation of the samples after learning machine analysis
(Fig. 1d; Supplementary Fig. 1). Random Forest analysis predicted
that most septins are affected in HCV-induced cirrhosis when
compared to normal liver, while septin 10 was less affected. This
was confirmed by individual boxplot performed on each septin
(Fig. 1e, P value were calculated by two-sided Student t-test).
These analyses showed that the expression of septin 7 and 2 is
massively affected in these samples (Fig. 1d,e). A weak error on
misclassification by class (confusion of 1.67%) was detected when
using the learning machine algorithm (Supplementary Fig. 1c).
Thus, we performed an unsupervised classification on these
samples with previously used septin expression (classification tree
with Euclidean distance and complete linkage (Fig. 1f)). This
unsupervised algorithm performed on 58 clinical samples allowed
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Figure 1 | Transcriptomic analysis of septin 9 in human cirrhosis. (a) R software was used to generate boxplot presents septin 9 expression in cirrhosis
and in normal liver samples of GSE14323 data set and to calculate mentioned P value of two-sided Student’s t-test. (b) The octameric complex of septins
contains septin 2 group and septin 6 group members, septin 7 and septin 9 which caps the two extremities of the rod shaped complex. (c) R software with
FactoMineR package was used to obtain unsupervised principal component analysis performed on GSE14323 with septin molecules: P value obtained on
first principal axis allowed discriminating normal liver from cirrhosis in GSE14323. (d) Mean decrease accuracy of predict variables during the ‘Septin’
Random Forest learning machine. (e) R software was used to generate boxplot of septins allows to discriminate cirrhosis from normal liver with GSE14323
and to calculate mentioned P value of two-sided Student’s t-test. (f) R software was used to perform heatmap by unsupervised classification with septin
molecules in GSE14323 (classification tree with Euclidean distance and complete linkage).
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the discrimination of two major groups of experiments with no
error of misclassification between normal liver and HCV-induced
cirrhosis samples. This result suggests that the expression of
septin protein family is deregulated in HCV-induced cirrhosis as
compared with that in the normal liver.
HCV assembles septin 9 which stabilizes microtubules.
Following the above described transcriptomic study, we
hypothesized that HCV could be responsible of the upregulation
of septin 9 in cirrhosis. To explore this possibility, Huh7.5 cells
were inoculated for 24, 48 and 72 h with HCV JFH-1 (Japanese
fulminate hepatitis 1), a genotype 2a strain, which produces
infectious particles in culture and recapitulates all steps of the
HCV life cycle33. Immunoblot data revealed a non-significant,
time-dependent increase of septin 9 expression in non-infected
cells, while septin 9 expression was significantly enhanced in
JFH-1-infected cells (Fig. 2a), with the highest expression at 72 h
of infection (Fig. 2a) when septin 9 formed bundles of filaments
surrounding the clusters of HCV core (Fig. 2b). Treatment of
Huh7.5 cells with two different septin 9 siRNAs (si1 and si3)
before their infection strongly reduced core expression (Fig. 2b,c).
These data suggested that HCV-regulated septin 9 assembly and
expression was required for core protein expression.
Thus, to further characterize the septin 9 filamentous structure,
we determined the presence of other septins. We focussed on
septin 2, the major ubiquitously expressed septin and the most
deregulated in HCV-induced cirrhosis (Fig. 1). In non-infected
cells, septin 2 formed short filaments that co-localized with
septin 9 (Fig. 2d,e). These filamentous structures containing
septin 2 and their co-localization with septin 9 were significantly
increased upon JFH-1 infection (Fig. 2d–f). Depletion of septin 9
using si3 disrupted septin 2 filaments and reduced its staining
when compared with that in control cells in both non-infected
and JFH-1-infected cells (Fig. 2d,e). These data were confirmed
by immunoblot analysis (Fig. 2g) and suggested the role of
septin 9 in the formation of septin filamentous structure,
consistent with previous reports32.
Next, we assessed the effects of septin 9 expression on
HCV-modulated microtubule (MT) network. Tubulin staining
indicated a strong MT network in HCV-infected cells
when compared with that of non-infected cells (Fig. 2h,i;
Supplementary Fig. 2a). Importantly, MTs co-localized with
septin 9 filaments and si3 severely destroyed MT filaments
(Fig. 2h–j), indicating a regulatory role of septin 9 in
HCV-dependent MT organization.
Septin 9 regulates LD behaviour and HCV replication. The
accumulation of LDs is an important feature of HCV infection4.
Thus, to understate the importance of septin 9 in HCV life cycle,
we investigated LDs. JFH-1 infection sharply increased LDs that
formed clusters co-localized with the core protein around the
nucleus (Fig. 3a), while si3 treatment markedly decreased LDs
(Fig. 3b) and their co-localization with core (Fig. 3c,d). A typical
profile of LD distribution was presented (Fig. 3e,f). In non-
infected cells, about 70% of LDs were present in the perinuclear
area and si3 treatment decreased the percentage to 55%. JFH-1
infection increased the perinuclear LDs up to 92% and septin 9
depletion decreased this level to 62% (Fig. 3g). These changes in
the level and distribution of LDs were accompanied by a 2.5-fold
increase of LD size in JFH-1-infected cells, while si3 decreased the
LD size by half (Fig. 3h). Similar changes were observed for LD
number (Fig. 3h). PLIN2 is among the best studied protein
associated with LDs and is considered as a marker of LDs34.
The strong increase in PLIN2 expression and its co-localization
with core observed in JFH-1-infected cells were abolished by si3
treatment (Supplementary Fig. 3) and emphasized the role of
septin 9 in HCV-induced LD accumulation. Finally, we revealed a
strong decrease of HCV genomic RNA after septin 9 knockdown
(Fig. 3i), suggesting a critical role of septin 9 in HCV replication.
We also analysed the transcript level of the five well-characterized
variants of septin 9 (i1 to 5) after JFH-1 infection. Isoform 1
mRNAs were the most abundant, while isoform 3 mRNAs were
almost undetectable (Supplementary Fig. 2b). Accordingly, the
following studies focused on septin 9 isoform 1 (Septin 9_i1) and
we used Huh7 cells stably expressing HCV full-length genomic
replicon from genotype 1b (Huh7R)35. This system permitted the
efficient expression of all viral proteins and is a convenient and
valuable tool for molecular studies. A decrease in both the core
and envelope E2 proteins was observed in Huh7R cells
transfected with si3 (Supplementary Fig. 4a). By opposite both
core and E2 expression increased in cells expressing septin 9_i1
compared with control cells (Supplementary Fig. 4b). Later,
septin 9_i1 and the LD characteristics were assessed by
immunofluorescence analysis. Septin 9_i1 assembled in
filaments surrounding the large clusters of LD and transfection
of si3 inhibited LD accumulation (Fig. 4a). Overall, profiles of LD
distribution and changes in LD morphology (Fig. 4b,c) were
similar to the results obtained using the JFH-1 strain (Fig. 3).
Septin 9_i1 filaments co-localized with endogenous septin 2
(Supplementary Fig. 5a), indicating that septin 9_i1 is integrated
in a hero-oligomeric structure composed of other septins
consistent with data in Fig. 2. Moreover, the ratio of the
intensity of exogenous septin 9_i1 revealed with an anti-V5 tag
antibody to the intensity of endogenous septin 9 detected with
septin 9 antibody was 1.1 (Supplementary Fig. 5b). Thus, we
concluded that septin 9_i1 expression was similar to that of
endogenous septin 9.
Although the first evidence for HCV interaction with LDs was
obtained from a study on the core protein, recent studies
indicated that the interaction of the HCV non-structural protein
NS5A with PLIN3 is essential for the recruitment of NS5A on
LDs to promote the release of HCV particles36,37. Interestingly,
increases in PLIN3 and NS5A expression were observed in
Huh7R cells expressing septin 9_i1 (Supplementary Fig. 6a).
These results were confirmed by immunoblot (Supplementary
Fig. 6b) indicating that septin 9_i1 regulated LDs growth and
HCV protein expression.
Septin 9 regulates neutral lipid metabolism. LD growth can be
mediated by several mechanisms, but, typically, its size expansion
involved an increase in the neutral lipid content, which essentially
consists of TAG and cholesterol ester5. Therefore, we analysed the
neutral lipid content of septin 9_i1-expressing cells. Transfection
of septin 9_i1 in Huh7R cells induced a threefold increase of TAG
and correlated with a decrease of diacylglycerol (DAGs) (Fig. 4d).
As a consequence, the ratio of TAG to DAG was greatly increased
(Fig. 4e). The fatty acid composition of TAG and DAG was also
analysed. The composition of these two lipids was very similar
and consisted mostly of C16 and C18 long chains (Fig. 4f).
Similar data were obtained using septin 9-depleted Huh7R cells
(Fig. 4g-i). A significant TAG decrease and an increase in DAG
were observed (Fig. 4g), suggesting a conversion of the TAG pool
into DAGs.
Diacylglycerol acyltransferase-1 (DGAT1) is one of the two
known DGAT enzymes that catalyse the final step in triglyceride
biosynthesis38. The role of DGAT1 in the trafficking of the HCV
core protein to LDs and its involvement in the production of
infectious HCV particles were reported39,40. Thus, we analysed
DGAT expression and we observed a significant increase in the
total intensity of the DGAT1 signal in septin 9_i1-expressing
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cells. Moreover, DGAT1 co-localized with septin 9_i1 filaments,
as shown at the highest magnification (Fig. 4j). Together, these
data indicated that septin 9 could also participate in LD growth
by regulating lipid biosynthesis.
MTs are required for septin 9-induced LD behaviour. Different
reports indicated that MTs play a role in the dynamics and
growth of LDs41,42. Furthermore, septins interact with MTs and
are essential for MT-dependent cell processes12,23,43. Therefore,
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Figure 3 | Septin 9 regulates core and LDs accumulation in JFH-1 infected cells and virus replication. (a) Huh7.5 cells were transfected with
non-targeting (control or Ctrl) or septin 9 siRNA (si3) for 24 h then infected with JFH-1 for further 72 h and stained for core (green) and LDs (red).
(b) LDs fluorescence intensity in 30 cells from two experiments performed as described in a. (c) Dot squares in a are presented in higher magnification.
The right panels present green, red, line profile blots of the pink lines. (d) Bar graphs show Pearson’s correlation coefficient (Rr) for co-localization between
core and LDs of 30 cells from two experiments. (e) Representation of the peripheral (black) and perinuclear (red) regions of the cell. (f) Radial profile plots
showing LD distribution between the peripheral (black) and the perinuclear regions (red) of cells indicated with the white arrows in a. (g) Quantification of
LDs in perinuclear and peripheral regions in 30 cells from two independent experiments performed as described in a. (h) LD size (left) and LD number
(right) in 30 cells from two independent experiments done as described in a. (i) Huh7.5 cells were transfected with non-targeting (control) or septin 9
siRNA (si3) for 24 h and infected with JFH-1 as in a for 72 h. Cells were analysed for septin 9 mRNA and HCV RNA level by qRT–PCR. Bar graphs show
results from 3 independent experiments. Values are means±s.e.m. Student’s t-test was used. *Po0.05, **Po0.001, ***Po0.0001. Scale bar, 10mm.
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Figure 4 | Septin 9 regulates TAG and DAG levels in Huh7R cells. (a) Huh7R cells transfected with empty vector (EV) or septin 9_i1 for 48 h were stained
for LDs (red) and V5 tag (green). Cells transfected with non-targeting (control) or septin 9 siRNA (si3) for 48 h were stained for LDs (red) and septin 9
(green). (b) Schematic representation shows the perinuclear and peripheral regions of the cell. Bar graphs represent LDs intensity in the perinuclear and
peripheral region of 36 cells from five independent experiments. (c) LD size and LD number in 36 cells from 5 independent experiments. (d–f) Huh7R cells
were transfected with either EV or septin 9_i1 cDNAs then analysed for triacylglycerol (TAG) and diacylglycerol (DAG). (d) Data represent nmol per 106
cells. (e) Ratio of TAG to DAG. (f) Distribution of fatty acid species in TAG and DAG according to carbon number in the acyl group. Results are obtained
from 3 independents experiments. (g–i) Huh7R cells transfected with non-targeting or septin 9 siRNA for 72 h were analysed for TAG and DAG as in d–f.
(j) Huh7R cells transfected with EV or septin 9_i1 were stained for V5 tag (red) and diacylglycerol acyltransferase-1 (DGAT1) (green). White squares
indicate the area shown in higher magnification. Bar graph represents DGAT1 fluorescence intensity in 50 cells from two independent experiments.
Values are means±s.e.m. Student’s t-test was used. *Po0.05, ***Po0.0001. Scale bar, 10mm.
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we postulated that MTs could play a role in septin 9-induced LD
growth. Consequently, we performed a nocodazole washout
(Fig. 5). Treatment of Huh7R cells expressing septin 9_i1 with
nocodazole resulted in the dispersion of LDs throughout the cell
and decreased their size. One hour after nocodazole removal, LDs
started to gather around the nucleus and increased in size. These
changes were accompanied by the partial recovery of the
microtubule filamentous structure (Fig. 5a). Finally, LDs were
restored to their initial size and relocated around the nucleus 3 h
after nocodazole removal (Fig. 5b–d). Taken together, these
results indicate that MT dynamics are required for septin 9 to
induce LD growth and perinuclear clustering.
PtdIns5P binds to septin 9 and promotes LD growth. To
further identify the mechanism underlying septin 9 assembly and
its role on LD, we assessed the importance of phosphoinositides
(PI). The phospholipid monolayer that surrounds LDs plays a
role in the regulation of LDs morphology. Phosphatidylcholine
stabilizes the tension and reduces LD growth, while phosphatidic
acid contributes to LD expansion44. PtdIns was also detected
on LD surface11, however, the presence and the role of its
phosphorylated derivatives, PIs, on LD growth have not been
investigated. Therefore, we identified the PIs that bind to septin 9
by performing a protein–lipid overlay assay using a glutathione-
S-transferase (GST)-tagged recombinant protein (Fig. 6a). Data
from the assay revealed that septin 9 bound specifically to mono-
phosphorylated PtdIns (PtdIns3P, PtdIns4P and PtdIns5P) and
the strongest interaction was observed with PtdIns5P while no
signal was detected using GST protein alone as a negative control
(Fig. 6a), supporting the specificity of the observed binding
signals.
Furthermore, we showed that PtdIns3P, PtdIns4P and
PtdIns5P promoted a significant increase in LD size compared
with non-treated cells, whereas PtdIns(4,5)P2 evaluated as a
non-binding septin PI, had no significant effect (Fig. 6b,c).
PtdIns5P was the most efficient (Fig. 6b,c), consistent with the
results in Fig. 6a. Moreover, septin 9 assembled surrounding the
LDs that became more visible upon the addition of PtdIns5P
(Fig. 6b). Overall, these data revealed the crucial role of mono-
phosphorylated PIs in the expansion of LDs and the organization
of septin 9 high-order structures. Thus, we focused on PtdIns5P,
which was the most effective on LDs. PtdIns5P specifically binds
to the plant homeodomain (PHD) finger found in many
chromatin-remodelling proteins, and the PHD domain of the
tumour suppressor inhibitor of growth (ING2) was proposed to
function as a receptor of PtdIns5P (ref. 45). We used the
biotinylated GST-tagged PHD domain of ING2 as a probe
to visualize cellular PtdIns5P, as previously described46. As
expected, compared with untreated cells, PtdIns5P addition
strongly increased both the PHD signal and the LD size and
confirmed that addition of exogenous PtdIns5P increased its
intracellular level (Supplementary Fig. 7a–c). To validate the
role of PtdIns5P on LDs, we used another approach based on
IpgD, the virulence factor of Shigella flexneri, which is a
PtdIns(4,5)P2-4-phosphatase responsible for the profound
increase of PtdIns5P in S. flexneri-infected cells47. Transfection
of Huh7R cells with GFP-tagged-IpgD cDNA (GFP-IpgD)
increased PtdIns5P signal (Supplementary Fig. 7d) and LD size
and accumulation (Fig. 6d).
PIKfyve regulates septin 9 filaments and LD accumulation. To
further study the interaction between septin 9 and PtdIns5P and
its importance in LD accumulation, we used YM201636, a
selective inhibitor of FYVE finger containing phosphoinositide
kinase (PIKfyve), a major contributor to the intracellular
production of PtdIns5P (ref. 48). First, the effect of YM201636
was verified by PtdIns5P immunostaining in Huh7R cells
(Fig. 7a). Subsequently, the cells were transfected either with an
empty vector or a septin 9_i1 construct and treated with
YM201636. Moreover LD size and level increased in cells
expressing septin 9_i1 and were surrounded by septin 9_i1
filaments as described in Fig. 4. YM201636 treatment profoundly
reduced the LD size (Fig. 7b,c and Supplementary Fig. 8a) and
decreased TAGs concomitantly with an increase of DAGs
(Supplementary Fig. 8b–d). Interestingly, YM201636 treatment
disrupted septin 9_i1 (Fig. 7b; Supplementary Fig. 8a) and
MT filaments and prevented both co-localization (Fig. 7c).
Furthermore, PtdIns5P addition to Huh7R cells transfected with
septin 9 siRNA partly rescued the disruption of MT filaments and
LD clustering caused by septin 9 depletion (Supplementary
Fig. 9). Thus, these data demonstrated that PtdIns5P is a crucial
regulator of septin 9 structural and functional features.
Interestingly our data revealed that both septin 9 and
HCV-regulated PtdIns5P levels. Indeed infection of Huh7.5 cells
using JFH-1 particles increased PtdIns5P (Supplementary
Fig. 10a). Moreover PtdIns5P increased in Huh7R cells compared
with naive Huh7 cells and transfection of the later cells with
septin 9_i1 cDNA significantly enhanced the PtdIns5P signal
(Supplementary Fig. 10b,c).
Septin 9 PBR is required for its assembly and LD growth.
Septins bind PIs in vitro via the polybasic region (PBR) near their
N terminus26,49. The conserved sequence encompassing residues
aa289 to aa294 is boxed in Fig. 8a. Thus, as another approach to
assess the importance of PI for septin 9 structural and functional
features, we generated a PBR-deleted mutant (septin 9_del1) from
the cDNA of V5-tagged septin 9_i1. The recombinant proteins
from the entire septin 9_i1 and the deleted construct were
produced in Escherichia coli, purified to near homogeneity, and
analysed by SDS gel electrophoresis (Fig. 8b). Coomassie blue
staining revealed a major band of the expected molecular weight
(70 kDa) for both septin 9_i1 and the deleted mutant, while some
lower molecular weight species co-purified with septin 9_i1
(Fig. 8b). Immunoblot (Fig. 8c) confirmed that all detected
protein bands were recognized by a V5-tag antibody. Purified
recombinant proteins were used to perform a lipid overlay assay.
Septin 9_i1 bound PtdIns3P, PtdIns4P, and PtdIns5P as expected,
although a signal was observed with phosphatidic acid and
PtdIns(3, 5)P2. The lipid-binding signal was strongly reduced
for septin 9_del1 (Fig. 8d). Subsequently Huh7R cells35 were
transfected with the septin 9_i1, septin 9_del1 cDNAs, or empty
vector (EV). Septin 9_i1 formed filaments whereas septin 9_del1
could not form filaments (Fig. 8e). Expression of septin 9_i1
increased LD in the perinuclear region compared to
EV-transfected cells (Fig. 8e,f). In contrast, septin 9_del1
expression significantly reduced the total level of LDs and their
perinuclear distribution (Fig. 8e,f). These changes in the LD
distribution were accompanied by significant decrease of the LD
size and number (Fig. 8g). Furthermore septin 9_i1 filament
structures co-localized with MTs. By contrast, the mutant septin
9_del1 lost the filamentous structure and co-localization with
MTs. The Pearson co-localization coefficient (Rr) between septin
9 and MTs dropped from 0.56±0.01 in cells expressing septin
9_i1 to 0.17±0.03 in cells expressing septin 9_del1 and the RGB
line profile showed a similarity between MTs and septin 9_i1
cellular distribution (Fig. 8h). These results indicate that PBR is
necessary for the formation of septin 9 filamentous structures and
LD growth. Moreover, PBR is involved in MTs organization
and highlighted the critical role of septin 9 in cytoskeleton
organization.
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Septin 9 regulates LD growth in naive cells. Unravelling this
new role of septin 9 in LD behaviour led us to examine its
relevance independently of HCV infection. We performed a set
of experiments using naive Huh7 cells. Septin 9_i1 expression
significantly increases LD size comparing to EV-transfected
cells (Supplementary Fig. 11a,b). Additionally, neutral lipids
analysis revealed an increase TAG in septin 9_i1-transfected
cells (Supplementary Fig. 11c,d). Expression of GFP-IpgD
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Figure 5 | Septin 9 regulates LDs in microtubules-dependent manner. (a) Huh7R cells transfected with septin 9_i1 were treated with nocodazole (33 mM)
for 2 h at 37 C and placed on ice for 1 h. Then cells were washed five times with ice-cold culture medium to remove the nocodazole and moved at 37 C for
indicated time in the figure before staining for V5 tag (green), LDs (red) and microtubules (grey) with b tubulin. (b) Schematic representation shows the
perinuclear and peripheral regions. (c) Percentage of LDs intensity in the perinuclear and peripheral regions of 20 cells from two independent experiments.
(d) LD size analysed in 20 cells from two independent experiments. Values are means±s.e.m. Student’s t-test was used. *Po0.05, **Po0.001,
***Po0.0001. Scale bar, 10mm.
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(Supplementary Fig. 11e,f) or the addition of exogenous mono-
phosphorylated PIs to huh7 cells increase LD size (Supplementary
Fig. 12a). In contrast, septin 9_del1 transfection or treatment with
YM201636 in septin 9_i1-transfected cells significantly decrease
LD size (Supplementary Fig. 12b), disrupted septin 9 filamentous
structure and its co-localization with MTs (Supplementary
Fig. 13a–c). Similar effects were observed on actin filaments in
septin 9_del1 expressing Huh7 cells (Supplementary Fig. 13d).
Taken together, these results indicate the fundamental role of
septin 9 and PtdIns5P in LD accumulation and cytoskeleton
dynamic independently of HCV infection.
Septin 9/PtdIns5P regulates sodium oleate-induced LD growth.
To emphasize the function of septin 9 and PtdIns5P in lipid
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homoeostasis, Huh7 cells were treated with sodium oleate
(0–200 mM), commonly used to induce LD formation. Neutral
lipid analysis revealed a concentration-dependent increase of
TAG and a decrease of DAG due to the addition of sodium oleate,
validating the effect of sodium oleate (Supplementary Fig. 14).
The immunofluorescence data indicated a dose-dependent
enlargement of the LDs and an increase of endogenous septin 9.
Remarkably, in cells supplemented with 200 mM sodium oleate,
septin 9 filaments were visible around the very large clusters of
LDs (Fig. 9a). Immunoblot data confirmed the gradual increase of
septin 9 expression with the sodium oleate concentration and a
concomitant increase of PLIN2 expression (Fig. 9b).
To further investigate the association of septin 9 with LD
formation, we performed membrane flotation assays37 (Fig. 9c,d)
using Huh7 cells and the same cells treated with 100 mM sodium
oleate as described in methods. Twenty-five fractions were
collected and assessed by western blotting for septin 9, septin 2.
PLIN2 and calnexin were analysed as markers of LDs and ER,
respectively. The lowest-density membrane fractions (fractions
1–8) are called ‘LD-rich’ and the fractions (9–15) represented
the ‘ER/endosome-rich’fractions, while the fractions (16–25)
contained soluble and aggregated proteins. In non-treated Huh7
cells, septin 9 was mainly found in the ER/endosome-rich and the
soluble/aggregated protein fractions, but not within low-density
LD-rich fractions (Fig. 9c, upper panels). Similar distribution
profiles were observed for septin 2 and calnexin, while PLIN2 was
detectable in ‘LD-rich’ fractions. These data suggested that, in
non-treated cells, septins are mainly associated with LDs in the
ER. This distribution changed in the presence of sodium oleate,
septin 9 and septin 2 increased in low-density LD-rich fractions
with high expression of PLIN2 and decreased from the
ER/endosome-rich fractions totally depleted of PLIN2. There
was no visible change in the distribution profile of the different
proteins among the soluble/aggregated protein fractions. Overall,
these results suggested that septin 9 and septin 2 are associated
with the ER site of LD biogenesis and sodium oleate promoted
LD biogenesis and enhanced septins association with LDs.
Subsequently, we explored the role of septin 9 and PtdIns5P on
oleate-induced LD accumulation. Transfection with septin 9_i1
cDNA of Huh7 cells treated with 100 mM sodium oleate increased
the LD size, while transfection with the septin 9_del1 construct or
with si3 septin 9 (Fig. 10a,b) and YM201636 treatment (Fig. 10c),
produced the opposite effect, indicating that septin 9 and
PtdIns5P regulated oleate-induced LD biogenesis.
Discussion
In this study, we showed a deregulation of septin expression in
HCV-induced cirrhosis compared with that in the normal liver.
Subsequent studies using HCV-infected cells revealed an
unexpected role for septin 9 in the control of cellular lipid
homoeostasis through its binding to PtdIns5P required for
microtubules stabilization and LD perinuclear accumulation. As
depicted in our model in Fig. 10d this new role of septin 9 was
also observed independently of the presence of HCV in naı¨ve cells
and in sodium oleate-induced LD accumulation. Additionally,
septin 9 regulates HCV replication and assembles around the
perinuclear clusters of the core in HCV-infected cells. Septin 9
promotes the perinuclear recruitment of proteins coating the LD
surface such as PLIN2 and PLIN3 as well as the HCV core and
the non-structural NS5A. Furthermore, PLIN3 playing an
essential role in the HCV replication process37.Thus, one could
speculate that HCV recruits septin 9 to control LD growth
and creates a lipid-enriched environment, facilitating HCV
replication. Septins are crucial cytoskeletal components that
are exploited by many pathogens such as S. flexneri,
Listeria monocytogenes23, Candida albicans50 and Chlamydia
trachomatis27. Moreover, septin 6 controls HCV replication via a
direct interaction with a RNA binding protein, acting as a scaffold
protein to facilitate the positioning of the HCV replication
complex29. However, the roles of the LDs were not investigated in
these studies related to septin/pathogen interactions. Here we
demonstrated that IpgD, the virulence effector of S. flexneri
increased the cellular content of PtdIns5P and induced LD
growth. Even though this result confirmed the role of PtdIns5P in
LD growth and accumulation, its enabled speculation on the
potential role of LDs in infection by S. flexneri. Therefore, the
findings of this study can be extended to other types of pathogens
beyond HCV.
Despite the numerous publications about LD biology, several
questions related to their biogenesis, growth and dynamics
remain unanswered1,4,44. LD formation likely occurs at the ER,
and different mechanisms are involved in LD growth, including
growth from nascent LDs in the ER or in the vicinity of the ER via
the incorporation of TAGs and phospholipids locally synthesized
into LDs. These proposed mechanisms arose from the
observations that key enzymes of phospholipid and neutral
lipid synthesis are present on the LD surface44. LDs might also
expand via fusion of existing LDs. These fusion processes include
the absorption of small LDs by large LDs mediated by Fsp27
(a 27 kDa fat-specific protein) enriched at the contact site between
LDs51,52. Fusion mechanisms can also be mediated via
phospholipid metabolizing enzymes that produce fusogenic
compounds at the LD surface53,54.This fusion between LDs
involves the SNARE proteins55. In this study, we demonstrated
that septin 9 significantly regulates the cellular content of TAG,
a neutral lipid component essential for LD biogenesis.
Furthermore, septin 9 promotes perinuclear accumulation of
neutral lipid synthesis enzymes such as DGAT1 and regulates the
expression of PLIN2 and PLIN3, two PLINfamily proteins crucial
for LD formation. These data support a role of septin 9 in LD
growth and biogenesis.
Nonetheless, we cannot rule out a role for septin 9 in LD fusion
mechanisms. LD fusions are MT-dependent processes42. In this
study, we demonstrated the requirement for dynamic MTs for
septin 9-induced LD growth. Furthermore, LD fusion and size is
related to the composition of the surrounding monolayer of
phospholipids, including PtdIns. Interestingly, we demonstrated
that septin 9 binds to mono-phosphorylated PtdIns, which is
consistent with previously published data for Saccharomyces
cerevisiae49. These PIs promote LD growth and are reminiscent
of the role of PtdIns4P in the homoeostasis of LDs in
yeasts56,57.
PtdIns5P is mainly present in the plasma and intracellular
membranes, including the smooth ER and Golgi58, and remains
the least characterized among the eight different PIs59. Notably,
PtdIns5P regulates septin 9 assemblies in high-order structures.
PtdIns5P partly rescued the loss of microtubule filaments induced
by septin 9 knockdown. These results are consistent with the
reported role for PIKfyve in microtubule-dependent vesicular
trafficking60 and strongly indicate a new role for PtdIns5P
as a partner of septin 9 in the regulation of MT and LD dynamics,
providing new insights on PtdIns5P biological role.
Consequently, we proposed that septin 9 could act as a scaffold
that establishes contacts between MTs and LDs via binding to
PtdIns5P that coats the surface of LDs and promotes LD growth
and intracellular movement.
These results revealed an unprecedented role for PIs in LD
biology in mammals, although a detailed mechanism awaits
further investigations. PIs are important regulators of membrane
trafficking in coordination with small GTPase proteins such as
ARF GTPase, Rab GTPases, and the subunits of the COPI
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complex. These different components are present on the LD
surface61,62. In addition, LDs interact with different cellular
organelles, including the ER, Golgi and mitochondria63.
Therefore, the existence of a different pool of LDs with a
specific PI and Rab GTPase composition could be postulated and
might help define LD identity as for endosomal compartments64.
Thus, a study of the contribution of PI signalling to LD biogenesis
and growth is of great interest in LD biology.
Septin 9
Septin 2
PLIN2
Calnexin
Septin 9
Septin 2
PLIN2
c
d
Calnexin
LD-rich
LD-rich LD-rich
ER/endosome-rich
ER/endosome
-rich
ER/endosome
-rich
a b
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
75
37
50
100
75
37
50
100
Non
treatment
Sodium
oleate
Septin 9
Septin 2
PLIN2
Calnexin
D
en
si
to
m
et
ry
D
en
si
to
m
et
ry
Non treatment Sodium oleate
11
11
11
11
33
33
33
33
55
55
55
55
77
77
77
77
99
99
99
99
1111
1111
1111
1111
1515
1515
1515
1515
1313
1313
1313
1313
FractionFraction
FractionFraction
FractionFraction
FractionFraction
8,000
4,000
0
2,000
1,000
0
0
2,000
1,000
0
3,000
2,500
0
5,000
2,000
2,000
0
0
4,000
4,000
6,000
6,000
0
10,000
15,000
5,000
4,000
2,000
Soluble/
aggregated proteins
Sodium oleate (µM)
0 50 100 200
0
0
0.5
0.5
1
1
1.5
D
en
si
to
m
et
ry
Se
pt
in
 9
/a
ct
in
Sodium
oleate (µM)
D
en
si
to
m
et
ry
PL
IN
2/
ac
tin
Septin 9
PLIN2
**
*
*
*
Sodium
oleate (µM)
0
0
50
50
100
100
200
200
Se
pt
in
 9
 
/ L
D
s
3D
 reconstruction
Sodium oleate (µM)
0 50 100 200
Septin 9
PLIN2
Actin
75
50
50
Figure 9 | Sodium oleate treatment increases septin 9 and LDs in the perinuclear region and in LD-rich fractions. (a) Huh7 cells were grown for 24 h.
The culture medium was supplemented with 0, 50, 100 or 200mM sodium oleate complex for 24 h then stained for septin 9 (green) and LDs (red).
The white squares indicate the zoomed area shown as a 3D reconstruction image with a white background. (b) Immunoblot analysis of septin 9 and PLIN2
in cells treated as in a. Bar graphs below show the analysis from three independent experiments. (c) Huh7 cells were treated or not with sodium oleate at
100 mM were submitted to membrane flotation assay and analysed by western blot for septin 9, septin 2, PLIN2 and Calnexin. (d) Densitometry analysis of
protein expression profile from western blot in c is shown. Values are means±s.e.m. Student’s t-test was used. *Po0.05, **Po0.001. Scale bar, 10mm.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12203
14 NATURE COMMUNICATIONS | 7:12203 | DOI: 10.1038/ncomms12203 | www.nature.com/naturecommunications
02
4
6
0
0.5
1
1.5
2
2.5
Control si3 septin 9 Control si3 septin 9
LD
 s
iz
e 
(µm
2 )
LD
 s
iz
e 
(µm
2 )
LD
 s
iz
e 
(µm
2 )
******
***
**
HCV, oleic acid, IpgD (Shigella)
Septin 9 PtdIns5P
LD LD
LD
LD
LD
M
icr
ot
ub
ule
s
Septin 9
PtdIns5P
0
0.5
1
1.5
2
2.5
3
EV
Se
ptin
 9_
i1
Se
ptin
 9_
de
l1
LD size
LD size LD size
EV Septin 9_i1 Septin 9_del1
V5 tag/LDs V5 tag/LDs V5 tag/LDs
Control si3 Septin 9 Control YM 201636
LDsLDsLDsLDs
a
cb
Endoplasmic reticulum
d
Figure 10 | Septin 9 and PtdIns(5)P are required for LDs accumulation in Huh7 sodium oleate-treated cells. (a) Huh7 cells transfected with EV,
septin 9_i1, or septin 9_del1 and treated with 100mM sodium oleate complex were strained for LDs and V5 tag. Dot squares indicates the zoom area
shown below in 3D reconstruction images. Bar graph shows LD size analysis of 33 cells from two independent experiments. (b) Huh7 cells transfected
with non-targeting (control) or septin 9 siRNA (si3) were treated with 100mM sodium oleate complex then strained for LDs and V5 tag. Bar graph shows
LD size analysis of 30 cells from two independent experiments. (c) Huh7 cells treated with 100mM sodium oleate then with 160mm YM201636 for
1 h before staining for LDs (red). Bar graphs present mean LD size of 60 cells from two independent experiments. Values are means±s.e.m. Student’s t-test
was used. **Po0.001, ***Po0.0001. Scale bar, 10mm. (d) Proposed model: HCV infection, oleic acid treatment and IpgD, the virulence factor of Shigella
flexneri may increase the cellular level of both septin 9 and PtdIns5P promoting their interaction and the subsequent organization of MTs to control LD
growth and accumulation.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12203 ARTICLE
NATURE COMMUNICATIONS | 7:12203 | DOI: 10.1038/ncomms12203 | www.nature.com/naturecommunications 15
In conclusion, this study provides new insights for research on
the increasing pathologies associated with lipid metabolism
disorders and cancer.
Methods
Chemicals. Phosphoinositides (PtdIns4P diC8 Cat#P4008, PtdIns5P diC4
Cat#P5004, PtdIns3P diC8 Cat#P3008, PtdIns(4,5)P2 diC8 Cat#P4508) and PIP
strip Cat#P-6001 were purchased from Echelon. Nocodazole Cat#487928 from
Calbiochem, YM201636 Cat#sc-204193 from Santa Cruz. Sodium oleate
Cat#o-7501 and Isopropyl b-D-1-thiogalactopyranoside (Cat# I6758) were
purchased from Sigma-Aldrich. Albumin BSA FFA Cat#126575 was from
Calbiochem. Purified septin 9-GST isoform 3 Cat# H00010801-P01 was purchased
from Clinisciences. Purified GST was from GenScript and V5 peptide control for
V5 antibody was from Novus Biologicals.
Cell lines and culture conditions. Human hepatocarcinoma cells Huh7.5, Huh7
and stable Huh7 cells expressing HCV genomic replicon (Huh7R) were used35.
Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) containing 4.5 g l 1 glucose and supplemented with 10%
heat-inactivated fetal bovine serum, 1% nonessential amino acids (GibcoBRL) and
1% penicillin/streptomycin (GibcoBRL). For Huh7R the described medium was
supplemented with G418 at 400 mgml 1. Cells were tested for mycoplasma
contamination weekly.
Cell treatments. Cells treatment with sodium oleate: complexes of sodium oleate
with BSA were prepared as previously reported65. Briefly, the solution containing
20mM sodium oleate and 2.4mM bovine serum albumin-fatty acid free (BSA FFA)
was heated to 55 C. The obtained complex was diluted in a pre-warmed culture
medium at indicated concentration before addition to the cells. The treated cells
were maintained in culture for 24 h and collected either for immunoblot or
immunofluorescence experiments.
Cells treatment with YM201636: cells were incubated for 1 h at 37 C in the
pre-warmed culture medium containing 160mM of YM201636 and collected for
analyses.
Cells treatment with PIs: PIs as a lyophilized powder were solubilized at 500 mM
in water by vortex. The solution was then diluted in Dulbecco’s phosphate-buffered
saline (DPBS) to the concentration indicated in the legends of the experiment.
Cells were washed with DPBS and the PIs solution was added to the cell for
indicated time.
JFH-1/HCVcc production and inoculation. Huh7.5 were infected with cell
culture-grown HCV JFH-1 at a multiplicity of infection (MOI) of 0.5 TCID50
cell 1 (50% tissue culture infective doses). After incubation at 37 C for 16 h,
the inoculum was removed then cells were washed three times with DMEM and
were further maintained in culture for the indicated time in the legend and text.
Reverse transcription and real-time PCR analysis. Total RNA was isolated using
RNAble, solution (Eurobio) and HCV RNA copy number was quantified using the
SuperScript III Platinium One-Step quantitative RT–PCR system (Invitrogen) and
a Ligth Cycler Fast Start DNA MasterPlus SYBR Green I mix (Roche). PCR was
carried on a Light Cycler 480 Real-Time PCR System (Roche). The sequence of the
Primer used in real-time RT–PCR analysis was presented in Supplementary
Tables 1 and 6-FAM-CCTTGTGGTACTGCCTGA-MGB (Applied Biosystems,
Foster City, CA, USA) was used as internal probe. To analyse the septin
9 transcript variants, total RNA was isolated using RNeasy Mini Kit 50 (Cat# 74104
QIAGEN) and applied to reverse transcription using RevertAid First Strand cDNA
Synthesis Kit (Cat#K1622 Fermentas). The cDNA was analysed by qPCR using
QuantiTect SYBR Green PCR Kit (Cat#204143 QIAGEN) and a 7500 Fast
Real-Time PCR System (Applied Biosystems). Reaction parameters were 30min at
50 C, 15min at 95 C, followed by 45 cycles of 15 s at 94 C, 30 s at 55 C and
30 s at 72 C. The triplicate mean values were calculated using GAPDH gene
transcription as reference for normalization. Used qRT–PCR primers sequences
are presented in the Supplementary Table 1.
siRNA, plasmids and transfection reagents. siRNAs from septin 9 were a Stealth
RNAi siRNA (si1: Cat#SEPT9HSS173895, si3: Cat# SEPT9HSS173897) from
Invitrogen and non-targeting siRNA (Cat#sc-37007) was from Santa Cruz. The
sequences targeting septin 9 (si1 and si3) are presented in the Supplementary
Table 2.
The cDNA of septin 9 isoform 1 transcript within pcDNA3.1/V5-His-TOPO
vector (cDNA septin 9_i1) was a gift from Dr Russell (CCRCB, Queens University
Belfast). The pET21d vector was a gift from Dr Pierre Nioche (INSERM UMR-S
1124, University of Paris Descartes).
cDNA septin 9_i1 vector was used as a template to generate pcDNA V5 septin
9_del1 using the QuikChange II XL Site-Direced Mutagenesis Kit (Cat#200521)
from agilent following the manufacturer’s recommendations. Therefore the septin
9_i1 V5/His tag and septin 9_del1 V5/His sequences have been amplified by PCR
from their pcDNA3.1/V5-His-TOPO vector. The resulting DNA fragments have
been inserted in a pET21d vector using In-Fusion HD Cloning System Cat#639648
(Clontech) pET21d in-frame with the C-terminal 6-histidine coding sequence of
the vector and according to manufacturer recommendations to obtain pET21d
septin 9_i1 V5/His and PET21d septin 9_del1 V5/His. All the primers sequences
were presented in the Supplementary Table 1.
The cDNA of GFP-IpgD was a gift from He´le`ne Tronche`re (INSERM UMR-S
1048, I2MC and Universite´ Paul Sabatier).
The transfection of cDNA and siRNA were performed using X-tremeGENE 9
DNA Transfection Reagent (Roche Diagnostics) and Lipofectamine RNAiMAX
reagent (Invitrogen) respectively following the manufacturer’s protocol. The
transfection was performed for 48 h unless indicated otherwise in the text.
Protein production and purification. E. coli BL21(DE3) Rosetta cells (#70953-3
Novagen) were transformed with pET21d septin 9_i1 V5/His and PET21d septin
9_del1 V5/His plasmids and all culture media contained 100mgml 1 ampicillin,
34 mgml 1 chloramphenicol. Cells from a single colony were used to seed an
overnight 20ml preculture of LB medium. One litre LB medium cultures from
these precultures were grown at 37 C with shaking to an optical density
(OD600 nm) of 0.9. The temperature was brought down to 28 C and protein
expression was then induced with 1mM Isopropyl b-D-1-thiogalactopyranoside
(IPTG) from Sigma (Cat# I6758) for 4 h. The cells were harvested by centrifugation
and the pellet was stored at  80 C until used. The cell pellet was suspended in
15ml of 50mM sodium phosphate pH 7.4, 300mM sodium chloride, 10% glycerol,
20mM imidazole, 0.1% Triton X-100, and one protease inhibitor cocktail EDTA
free tablet (Roche). Cell lysis was performed by sonication on ice and the cell lysate
was clarified by centrifugation for 30min at 4 C to 40,000g. After filtering the
supernatant the protein was isolated on a 1ml metal affinity column (HisTrap HP,
GE Healthcare) pre equilibrated in 50mM sodium phosphate pH 7.4, 300mM
sodium chloride, 10% glycerol, 20mM imidazole and eluted with 50mM sodium
phosphate pH 7.4, 300mM sodium chloride, 300mM imidazole. The fractions
containing the protein of interest were further purified by cation exchange
chromatography. The pooled fractions were diluted with a 1:5 ratio to a final
solution of 30mM tris pH8, 100mM NaCl, 1mM EDTA and then incubated with
1ml of a strong cation exchange resin (Macro-Prep 25S, BioRad). The resin was
packed in a column and eluted with a 100–600mM NaCl linear gradient. Fractions
containing the majority of protein were obtained B350mM NaCl. Septins were
then flash-frozen and stored at  80 C.
Primary antibodies. Anti septin 9 Cat#ab38314 (WB:1/500, IF:1/25), anti HCV
core Cat#ab2740 (WB:1/1,000, IF:1/100), anti atubulin Cat#ab15246 (WB:1/1,000,
IF:1/100), anti septin 2 Cat#ab88657(WB:1/500, IF:1/50), mouse and rabbit anti-V5
tag Cat#ab27671 (WB:1/1,000, IF:1/400), Cat#ab9116 (WB:1/1,000, IF:1/400)
respectively and anti ADFP/PLIN2 Cat#ab52355 (WB:1/2,000, IF:1/100) were from
abcam; anti btubulin Cat# T4026 (WB:1/1,000, IF:1/100) and anti TIP47/PLIN3
Cat#HPA006427 (WB:1/1,000, IF:1/100) from Sigma-Aldrich; anti-Actin
Cat#sc-1616 (WB:1/1,000) and anti-PLIN2 Cat#sc-32450 (WB:1/250, IF:1/25), anti
DGAT1 Cat#sc-32861 (IF:1/100) from Santa Cruz Biotechnology, anti HCV NSA
Cat#HCM-131-5 (WB:1/1,000, IF:1/100) from amsbio. The mouse antibody to
HCV envelope protein E2 (WB:1/500) was a gift from Dr Jean Dubuisson
(CIIL, Lille, France)66.
Secondary antibodies and dyes. Anti mouse IgG-HRP and anti rabbit IgG-HRP
form GE healthcare (WB:1/1,000). Anti-goat IgG-HRP Cat#sc-2020 (WB:1/1,000)
from Santa Cruz. Alexa Fluor 633 Cat#A21136, A21070 and A21082 (IF:1/100),
Alexa Fluor 568 Cat#A11004, A11011 and A11057 (IF:1/100), Alexa Fluor 488
Cat#A11001, A21206 and A21202 (IF:1/100), streptavidin Alexa-488 Cat#S32354
(IF:1/100), streptavidin Alexa-568 Cat#S11226 (IF:1/100). Actin was stained with
Alexa Fluor 594 phalloidin Cat#a12381 (IF:1/100) and nuclei with Hoechst
Cat#H21486 (IF:1/5,000), both are from Invitrogen. Lipophilic fluorescence dye LD
540 (IF:1/100) from Christoph Thiele (Bonn University, Germany), was used to
stain lipid droplets67.
GST-2XPHD preparation. The GST-2XPHD probe was produced in BL21
RILþ bacteria strain (Stratagene) and purified with glutathione Sepharose 4B
(Amersham). After dialysis in PBS overnight and concentration with Vivaspin 500,
MCO 10000, the recombinant protein was biotinylated using the BiotinTag Micro
biotinylation kit (Sigma-aldrich) according to the manufacturer.
Immunofluorescence. Cells were grown on coverslips, fixed with paraformalde-
hyde 4% for 20min and permeabilized for 20min at 37 C using the permeabilizing
buffer (PFS): DPBS containing saponin (Cat#10294440 Fisher scientific)
0.025% m.v 1, gelatin from cold water fish skin (Cat#G7041 Sigma 0.7% m.v 1).
Then cells were incubated with primary antibody for 2 h washed three times for
5min with PFS and incubated with the appropriate secondary antibodies or
with the dye for 90min. The coverslips were mounted using Prolong Gold
(Cat#P36934 Invitrogen). For PtdIns5P staining the cells on coverslips were fixed
and permeabilized as described above and then incubated with recombinant
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Bio-GST-2XPHDING2 (prepared as describe above) in 1% BSA-PBS for 1 h.
Following incubation, cells were washed and incubated for another hour with
streptavidin Alexa-488 (1/300) (Invitrogen) and Hoechst for nuclei staining,
mounted and analysed for immunofluorescence.
Images acquisition and analysis. Images acquired with a Leica TCS SP5 AOBS
tandem confocal microscope were analysed by Icy bioimage analysis software for
3D reconstruction. For colocalization analysis, images were treated by ImageJ
software, the plugin ‘Intensity Correlation Analysis’ was used to generate the
Pearson’s correlation coefficient (Rr) which range from  1 (perfect exclusion) to
þ 1 (perfect correlation).
To determine LD distribution in cells, the plugin ‘Radial profil’ was used. For
analysis, a circle was defined at the periphery of each cell and the plugin produces a
profile plot of normalized integrated intensities around concentric circles as a
function of distance from a point in the image, considered here as the centre of the
cell. The concentric circles were assembled in three circle bands, the first
corresponding to the area of the nuclei and the rest corresponding to the cytoplasm
was divided in two equal bands (the band near the nuclei is considered as the
‘perinuclear’ and the other the ‘periphery’). The intensity in each band was
calculated from the total integrated intensities around concentric circles present in
the band.
To calculate the size and number of LDs, images obtained by confocal
microscopy were processed by background subtraction and standardized
thresholding (default), cell ROI was made by free hand selection tool, then LDs size
and number was obtained by ImageJ analyse particles function (particle area less
than 0.01 mm2 were excluded).
Immunoblot. Cells were washed with ice-cold DPBS and lysed on ice using the
following buffer: 20mM Tris, HCl, 100mM NaCl, 1% Triton X-100 at PH 7.4
containing protease inhibitors (cOmplete ULTRA Cat#05892970001 Roche). The
proteins were separated on SDS–PAGE and electrotransferred onto nitrocellulose
membrane. After transfer, the membrane was saturated in DPBS containing 0.1%
Tween 20 and 5% milk. Primary antibodies were added overnight at 4 C or for 2 h
at room temperature depending on the antibody. The membranes were washed
with DPBS and incubated for 1 h at room temperature with appropriate secondary
antibody coupled with peroxidase. ECL plus kit (Cat#32132 Thermo Scientific) was
used for protein detection. Chemiluminescent signal was detected by G:BOX
Chemi Fluorescent & Chemiluminescent Imaging System from SYNGENE. Blot
quantification was done using ImageJ software.
Blot Scans are presented in the figures and the uncropped scan are supplied in
Supplementary Fig. 15.
PIP strip overlay assay. Membranes PIP Strips (Echelon Biosciences) were
blocked with 3% BSA FFA dissolved in phosphate-buffered saline (PBS) containing
0.1% Tween 20 (3% BSA FFA PBS-T) at room temperature for 60min, then
incubated overnight at 4 C with the same buffer containing the purified protein of
interest at a concentration of 0.5 mgml 1 or the purified corresponding tag (V5 or
GST) at equivalent molar concentration used as controls. The membranes were
washed and bounded proteins were detected with suitable antibody.
Neutral lipids analysis. This analysis was performed using the facility service of
Metatoul in Toulouse (http://www.metatoul.fr). One million of cells were used for
lipid extraction according to Bligh and Dyer68 using dichloromethane/methanol/
water (2.5:2.5:2.1, v/v/v) mix, in the presence of the internal standards: 4 mg of
stigmasterol, 4 mg of glycerid dimyristoleate, 4 mg of cholesteryl heptadecanoate,
8 mg of glyceryl trinonadecanoate. Organic phases were collected and evaporated to
dryness and neutral lipids were separated through a SPE cartridge. Briefly SiOH
cartridge (200mg, Macherey Nagel) was equilibrated with 2ml of dichloromethane
and the lipid extract was put down in 20 ml of a solution of dichloromethane
containing 10% omethanol and loaded. Neutral lipids were eluted with 2ml of the
same mixture. The final extract were concentrated and dissolved in 20 ml of
ethyl acetate. One microlitre of the lipid extract was analysed by gas-liquid
chromatography on a FOCUS Thermo Electron system using an Zebron-1
Phenomenex fused silica capillary columns (5m 0,32mm i.d., 0.50 mm film
thickness)69. The temperature of the Oven was programmed from 200 to 350 C at
a rate of 5 C per min and the carrier gas was hydrogen (0.5 bar). The injector and
the detector were at 315 and 345 C, respectively.
Membrane flotation assay. The assay was performed as recently reported37.
Huh7 cells treated with 100mM sodium oleate for 24 h were trypsinized, washed
and counted. Cells (15 106) total for each sample were resuspended in 1.75ml
PBS-containing 0.25M sucrose (PBS/sucrose) supplemented with protease
inhibitor cocktail (Sigma). The cells were then lysed with 200 passages in a tight
fitting dounce homogenizer to ensureB90% lysis. The cell lysate was then spun at
2,500g for 10min at 4 C to pellet cellular debris and nuclei. Equal amounts of
protein (2.5mg) for each cell type was adjusted in volume to 1ml with PBS/sucrose
and mixed with 1ml of 60% iodixanol (Sigma) resulting in a 30% iodixanol
concentration. A discontinuous iodixanol gradient (10%, 20%) was layered on top
of the lysate/iodixanol mixture, and the gradient was spun at 200,000g for 16 h at
4 C in a MLS 50 Rotor. A total of 25 fractions were collected from top to bottom.
The fractions were mixed 1:1 with Laemmli buffer for immunoblot.
Transcriptome analysis. Transcriptome data set GSE14323 (ref. 31) was
downloaded from NCBI website (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE14323): normalized matrix by users (RMA method in the R affy
package) was employed to realize analysis. This data set is composed of 19 control
samples of normal liver and 49 samples of cirrhosis. R software version 3.2.2 was
employed to perform, principal component analysis, boxplots, heatmap, two-sided
Student t-test, also algorithm of random forest (RF). The learning machine
application RF was performed by initializing the function tuneRF to determine the
mtry parameter with the optimal error of bag. The algorithm was implemented
with a learning based on 500 classification trees with the optimal mtry parameter
previously determined70.
Statistical analyses. Unpaired Student’s t-tests was used and statistical
significance was determined at *Po0.05; **Po0.001, ***Po0.0001.
Data availability. The data that support the findings of this study are available
from the corresponding author upon request. Transcriptome data set GSE14323
(ref. 31) was downloaded from NCBI website (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE14323).
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